Pharmacologic treatment of constipation in cancer patients

Cancer Control

Volumn 11, Issue 3 SUPPL., 2004, Pages 10-18

  Avila, Jorge G ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

17 METHYLNALTREXONE; ALVIMOPAN; ANTACID AGENT; ANTIEMETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTINEOPLASTIC AGENT; ANXIOLYTIC AGENT; BISACODYL; CASCARA; CASTOR OIL; CITROMA; GLYCEROL; GOLYTELY; IRON; LACTULOSE; LAXATIVE; MACROGOL 3350; MAGNESIUM CITRATE; MAGNESIUM HYDROXIDE; MINERAL OIL; NALOXONE; NULYTELY; OPIATE; OPIATE ANTAGONIST; OSMOTIC AGENT; PROKINETIC AGENT; SENNA EXTRACT; SEROTONIN 3 ANTAGONIST; SODIUM DIHYDROGEN PHOSPHATE; SPASMOLYTIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ABDOMINAL CRAMP; ABDOMINAL DISTENSION; ABDOMINAL PAIN; ANXIETY DISORDER; ASPIRATION PNEUMONIA; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RISK; CLINICAL TRIAL; COLON CANCER; CONSTIPATION; DEHYDRATION; DIAPHORESIS; DIETARY FIBER; DOSE RESPONSE; DROWSINESS; DRUG DOSAGE FORM; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG MECHANISM; DYSPNEA; ELECTROLYTE DISTURBANCE; EXTRAPYRAMIDAL SYMPTOM; FECES IMPACTION; FLATULENCE; FLUID INTAKE; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPOKALEMIA; INTESTINE OBSTRUCTION; MALABSORPTION; MELANOSIS; NAUSEA; PATHOPHYSIOLOGY; PROPHYLAXIS; RESTLESSNESS; REVIEW; TACHYCARDIA; TOXICITY; URINE COLOR; WITHDRAWAL SYNDROME;

EID: 2942625640     PISSN: 10732748     EISSN: None     Source Type: Journal    
DOI: 10.1177/10732748040110s303     Document Type: Review

References (20)

1. McMillan SC. Assessing and managing narcotic-induced constipation in adults with cancer. Cancer Control. 2004;11(3 suppl 1):3-9.
2. Smith S. Evidence-based management of constipation in the oncology patient. Eur J Oncol Nurs. 2001;5:18-25.
3. O'Mahony S, Coyle N, Payne R. Current management of opioid-related side effects. Oncology (Huntingt). 2001;15:61-73,77.
4. Choi YS, Billings AJ. Opioid antagonists: a review of their role in palliative care, focusing on use in opioid-related constipation. J Pain Symptom Manage. 2002;24:71-90.
5. Wright PS, Thomas SL. Constipation and diarrhea: the neglected symptoms. Semin Oncol Nurs. 1995;11:289-297.
6. Sykes NP. An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer. Palliat Med. 1996;10:135-144.
7. Curry CE, Tatum-Butler D. Laxative products. In: Covington TR, Lawson LC, Young LL, eds. Handbook of Nonprescription Drugs. 10th ed. Washington, DC: American Pharmaceutical Association; 1993:219-236.
8. Lacy CF, Armstrong LL, Goldman MP, et al, eds Drug Information Handbook. 11th ed. Hudson, Ohio: Lexi-Comp Inc; 2003.
9. Schiller LR. Clinical pharmacology and use of laxatives and lavage solutions. J Clin Gastroenterol. 1999;28:11-18.
10. Doughty DB. When fiber is not enough: current thinking on constipation management. Ostomy Wound Manage. 2002;48:30-41.
11. Scarlett Y. Medical management of fecal incontinence. Gastroenterology. 2004;126(1 suppl 1):S55-S63.
12. Gerber L, Hicks J, Shah J. Rehabilitation of the cancer patient. In: Devita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 6th ed. Baltimore, Md: Lippincott Williams & Wilkins; 2001:3089-3110.
13. Fallon M, O'Neill B. ABC of palliative care: constipation and diarrhea. BMJ. 1997;315:1293-1296.
14. Wong PW, Kadakia S. How to deal with chronic constipation: a stepwise method of establishing and treating the source of the problem. Postgrad Med. 1999;106:199-200,203-204,207-210.
15. Cleveland MV, Flavin DP, Ruben RA, et al. New polyethylene glycol laxative for treatment of constipation in adults: a randomized, double-blind, placebo-controlled study. South Med J. 2001;94:478-481.
16. Dosh SA. Evaluation and treatment of constipation. J Fam Pract. 2002;51:555-559.
17. Foley KM. Supportive care and quality of life: management of cancer pain. In: Devita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 6th ed. Baltimore, Md: Lippincott Williams & Wilkins; 2001:2997-3011.
18. Agra Y, Sacristan A, Gonzalez M, et al. Efficacy of senna versus lactulose in terminal cancer patients treated with opioids. J Pain Symptom Manage. 1998;15:1-7.
19. McNicol E, Horowicz-Mehler N, Fisk RA, et al. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain. 2003;4:231-256.
20. Thomas J, Portenoy M, Moehl C, et al. A phase II randomized dose-finding trial of methylnaltrexone for the relief of opioid-induced constipation in hospice patients. Proc Annu Meet Am Soc Clin Oncol. 2003;22:729. Abstract 2933.